Chemistry - A European Journal · 2011 · 96 citations · 34 references
PharmacyMedicinal ChemistryOncologyCancer PharmacologyChemotherapyDrug DesignCancer NanomedicineCarbene ComplexesCytotoxic ChemotherapyCytotoxicity AssessmentCytotoxicity EvaluationHeterocyclic ChemistryAnticancer ActivityCytotoxicity AssaysPlatinum Compounds
Antitumor AuI–NHC: Gold(I) N-heterocyclic carbene complexes exhibit marked cytotoxicity to human tumor cell lines. The cytotoxicity is dependent on the group bound to the gold–NHC moiety: [Au(OH)(IPr)] (1) and [Au(IPr)Cl] (2) are most effective. There was no difference between the cytotoxic effects on normal prostate or breast epithelial cells compared to tumor cells from the same tissue. The active compounds were more potent than cisplatin. Detailed facts of importance to specialist readers are published as ”Supporting Information”. Such documents are peer-reviewed, but not copy-edited or typeset. They are made available as submitted by the authors. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
34
Platinum Compounds: a New Class of Potent Antitumour Agents
Barnett Rosenberg, Loretta Vancamp, James E. Trosko et al. · Nature · 1969 · 3.9K citations
The status of platinum anticancer drugs in the clinic and in clinical trials
Nial Wheate, Shonagh Walker, Gemma E. Craig et al. · Dalton Transactions · 2010 · 1.6K citations
Medicine, Oncology, Pharmacology +15
James L. Hickey, Rasha A. Ruhayel, Peter J. Barnard et al. · Journal of the American Chemical Society · 2008 · 583 citations